Kura Oncology KURA
NASDAQ KURA
$9.61 -0.24 (-2.48%)
As of: Oct 23, 2026 · 3:59 PM EDT

Kura Oncology (KURA) Other non-cash items (2014 - 2021)

Updated

Analysis

Kura Oncology (KURA) Other non-cash items (2014 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Kura Oncology 858.78 Mn -1.46 Bn 20.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -399,000.00
Mar 31, 2015 500,000.00
Dec 31, 2014 500,000.00
API Access

Kura Oncology Other non-cash items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=KURA&period=max&api_key=YOUR_API_KEY